Hepatitis C News

Hepatitis C infection rates continue to increase in Northern Europe in recent years among younger men who have HIV and have sex with men, with those more recently infected with HIV showing higher rates of HCV infection, according to a recently published article.

FDA announced the approval of Vosevi for the treatment of adults with chronic hepatitis C genotypes 1 through 6, according to an agency press release.

Implementation of an electronic health record-based prompt significantly increased hepatitis C screening rates among baby boomers in primary care.

Adults with diabetes treated for hepatitis C who achieve sustained virologic response after treatment with direct-acting antiviral agents experienced decreased HbA1c and decreased insulin use compared with those who did not achieve sustained virologic response, study data show.

The direct-acting antiviral combination of grazoprevir, ruzasvir and uprifosbuvir, with or without ribavirin, for either 16 or 24 weeks was safe and effective for patients with hepatitis C who had previously failed NS5A inhibitor-containing treatment, according to results of two phase 2 studies.

Recently published data showed a link between sustained virologic response and a reduced risk for hepatocellular carcinoma among patients treated with direct-acting antivirals for hepatitis C.

The Trump administration has named Georgia health commissioner Brenda Fitzgerald, MD, to be the next CDC director.

The standard schedule of hepatitis B vaccination was safe and showed good immunogenicity among patients who were already infected with hepatitis C virus, according to recently published findings from China.

Researchers observed a significantly high sustained virologic response among patients coinfected with HIV and hepatitis C who were enrolled in the French nationwide ANRS CO13 HEPAVIH observational cohort study, according to a recently published report.

President Donald J. Trump has nominated Jerome M. Adams, MD, MPH, who has advocated for needle exchange programs, to be the next U.S. Surgeon General.